Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

Completed · Phase 1/Phase 2

Conditions studied: Keloid, Scleroderma, Localized, Acne Keloidalis, Scars, Granuloma Annulare

In brief

This research study will evaluate the effectiveness of high dose UVB light therapy in the treatment of keloid (or hypertrophic scar), scleroderma, acne keloidalis nuchae, old burn scars, granuloma annulare or related conditions.

Key facts

Study ID

NCT00129428

Run by

University of Michigan

People needed

33

Starts

2002-08-01

Expected to finish

2009-01-01

Last updated by the study team

2015-05-01

Who can join

Age: 10 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In good general health and between 10-80 years of age.
• Willing and able to receive UVB, as directed in the protocol; make evaluation visits; follow protocol restrictions; and sign a written, witnessed, informed consent form.
• Have a clinical diagnosis of keloid, scleroderma, old burn scars, granuloma annulare, or acne keloidalis nuchae.
• No disease states or physical conditions that would impair evaluation of the test site
• Must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study.

You may not qualify if…

• Have a history of photosensitivity (development of hives or bumps with exposure to light) or experience hypersensitivity in a UVB photo-provocation test.
• Have participated in another investigational study in the past 4 weeks, taken oral therapy for skin condition, or on photosensitizing medications.
• Pregnant, nursing, or planning to become pregnant during the study.

Where it is running

• University of Michigan Department of Dermatology — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.